Elizabeth Whalley Buono

Liz began her professional career as a medical/surgical and psychiatric nurse in the Boston area, transitioning that experience into what would become an extensive 13-year tenure in the pharmaceutical industry with Parke-Davis/Warner Lambert and Pfizer. She launched her legal career at Wiley, Rein and Fielding, LLP in Washington, DC, where she supported consumer product, pharmaceutical, biotech and device firms on a wide range of federal and state regulatory issues. In 2003, Liz joined Altria Client Services as Regulatory and Senior Counsel, managing the legal and health ethics considerations associated with clinical research and new product development activities undertaken in pursuit of tobacco harm reduction. In 2009, Liz joined MWV / Westrock to help establish and grow the company’s global adherence business. More recently, through her private consultancy, Liz supported healthcare innovation efforts undertaken by, among others, the Arcady Group, Tenacia, Novartis and the Bill and Melinda Gates Foundation and she also served as the Life Sciences Practice Group Lead Partner at Hancock Daniel. Among other public health pursuits, Liz serves on the U.S. Food and Drug Administration’s Working Group to Enhance Opioid Safety and the Centers for Disease Control’s PROTECT Initiative.

Liz received her BSN from Boston College School of Nursing and earned her MBA in Executive Management from St. John’s University College of Business Administration. She received her JD in Health Law and Economics from George Mason University and is HCCA certified in Healthcare Compliance and Healthcare Research Compliance. She is deeply involved at the state level in children’s health issues and serves on several boards in support of that work including Early Impact Virginia, Families Forward Virginia, Virginia Center for Health Innovation and the Medical College of Virginia Foundation.